LEVI
Levi Strauss & Co.
LEVI has the edge over NIO overall, supported by lower modeled downside.
NIO
NIO Inc.
NIO offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
LEVI Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Strong |
LEVI's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
LEVI PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 12x | $18.30 | -24% |
| Forward | 15x | $24.04 | — |
| Fair | 16x | $23.57 | -1.9% |
| Current | 16x | $24.04 | — |
| Expensive | 38x | $55.97 | +133% |
Historical ranges are pointers, not guarantees.
LEVI's PE is in its fair range at 16x. If earnings grow as analysts expect, today's price would be 15x next year's earnings.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
LEVI Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for LEVI, with profitability improving.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect NIO's losses to shrink, with revenue growing.
LEVI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.57 | +5.2% |
| Q3 2026 | $1.49 | -2% |
| Q2 2026 | $1.61 | +58% |
| Q1 2026 | $1.56 | +75% |
| Q4 2025 | $1.45 | +179% |
| Q3 2025 | $1.52 | +311% |
| Q2 2025 | $1.02 | +200% |
| Q1 2025 | $0.89 | +197% |
| Q4 2024 | $0.52 | -16% |
LEVI has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
LEVI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $1.6B | +4.3% |
| Q2 2026 | $1.6B | +8% |
| Q1 2026 | $1.7B | +14% |
| Q4 2025 | $1.8B | -4% |
| Q3 2025 | $1.5B | +1.8% |
| Q2 2025 | $1.4B | +0.3% |
| Q1 2025 | $1.5B | -2% |
| Q4 2024 | $1.8B | +12% |
LEVI's revenue has picked up after three years of holding roughly level: $1.6B last quarter, up 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +3 points |
| Q2 2026 | 7.8% | +0.4 points |
| Q1 2026 | 11% | -1.2 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 11% | +8.8 points |
| Q2 2025 | 7.5% | +5.9 points |
| Q1 2025 | 13% | +13 points |
| Q4 2024 | 12% | +2.3 points |
LEVI has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over LEVI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
LEVI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.3M | +$83.7M |
| Q2 2026 | $230.9M | +58% |
| Q1 2026 | $152.1M | +$166.2M |
| Q4 2025 | $215.7M | -6.9% |
| Q3 2025 | -$39.4M | -1813% |
| Q2 2025 | $146M | -34% |
| Q1 2025 | -$14.1M | -107% |
| Q4 2024 | $231.6M | +14% |
LEVI generated $643M in free cash flow over the past year, up 98% from the year before.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO's free cash flow was $0 over the past year, against −$2.5B the year before.
LEVI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.4x | Very low |
| Q2 2026 | 0.2x | Very low |
| Q1 2026 | 0.4x | Very low |
| Q4 2025 | 0.3x | Very low |
| Q3 2025 | 0.5x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.6x | Very low |
| Q4 2024 | 0.7x | Very low |
LEVI's net debt is less than a year of its operating earnings (EBITDA).
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
LEVI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 61.3 | Neutral |
| Stochastic | 71.3 | Neutral |
LEVI's weekly RSI is 61 (neutral) and its Stochastic is 71 (neutral).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
LEVI PE vs Consumer Cyclical Sector
| Metric | LEVI | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 10% below |
| PE % | 50 | 47 | 3 pts above |
LEVI is trading at 16x earnings, a 10% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
LEVI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $21.2 | 14% above |
| 20 week MA | $22.1 | 8.7% above |
| 50 week MA | $21.8 | 10% above |
| 100 week MA | $20.3 | 18% above |
| 200 week MA | $18.7 | 29% above |
LEVI has the edge over NIO on trend strength, trading above more of its moving averages.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
LEVI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.3 | $20.6 | +7.1% |
| 2021 | $20.6 | $24.6 | +19% |
| 2022 | $24.6 | $15.5 | -37% |
| 2023 | $15.5 | $16.5 | +6.8% |
| 2024 | $16.5 | $17.2 | +3.9% |
| 2025 | $17.2 | $21.1 | +23% |
| 2026 YTD | $21.1 | $24.0 | +14% |
LEVI has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.